Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05248763

Taiwan Cancer Moonshot Project

Taiwan Cancer Moonshot Project: 1. Next-generation Pathway of Taiwan Cancer Precision Medicine (Subjective Aim 1- Taiwan Cancer Moonshot Project); 2. Development of Novel Treatments for Major Diseases (Subproject 5 - Multiomic Big Data-based Intelligent Navigation System for Precision Oncology)

Status
Recruiting
Phase
Study type
Observational
Enrollment
4,190 (estimated)
Sponsor
Academia Sinica, Taiwan · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to establish multiomic big data under strictly collected clinical samples from tumors, adjacent normal tissue, blood, and clinical data then analyze by using integrated proteomics and genetics platform.

Detailed description

Multiomic integrative analysis is an effective strategy to facilitate the investigation of molecular mechanism, cause, and early intervention of specific diseases. Gastric cancer is specifically chosen for our research target to decrease its incidence and improve survival. To increase precision diagnosis, prognosis and precision therapy, patients from Taiwan are selected as cohort subjects. The aim of this study is to establish multiomic big data under strictly collected clinical samples from tumors, adjacent normal tissue, blood, and clinical data then analyze by using integrated proteomics and genetics platform. Genome, transcriptome, genomic methylation, proteomics, and post-translational modification will be used to construct a map for determine the in-depth carcinogenesis of gastric cancer and strategies for cancer early diagnosis, prevention, and targeted treatments.

Conditions

Timeline

Start date
2022-02-21
Primary completion
2026-12-31
Completion
2035-12-31
First posted
2022-02-21
Last updated
2022-07-20

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05248763. Inclusion in this directory is not an endorsement.